Congresswoman Shelley Berkley will face further scrutiny from the House Ethics Committee. The watchdog decided to formally investigate allegations that the Las Vegas congresswoman lobbied to influence the Administration's decisions about kidney medicine at UMC in ways that helped her husband's medical practice. She has also sponsored legislation that improves federal support for kidney services. So will this hurt Berkley's campaign for Nevada's US Senate seat? Is there more to be discovered? Or did the whole story come out in the original report from the New York Times?
Karoun Demirjian, Washington correspondent, LV Sun